Previous 10 | Next 10 |
Leading drug containment provider to release a unique offering including both COP and COC pre-fillable syringes (PFS), adding to its existing glass PFS portfolio, providing customers with the broadest choice for PFS Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of d...
Stevanato Group S.p.A. (STVN) Q3 2022 Earnings Conference Call November 8, 2022 8:30 AM ET Company Participants Lisa Miles - SVP Investor Relations Franco Stevanato - Executive Chairman Franco Moro - Chief Executive Officer Marco Dal Lago - Chief Financial Of...
Stevanato Group press release ( NYSE: STVN ): Q3 Non-GAAP EPS of $0.14 beats by $0.01 . Revenue of $245.3M (+14.4% Y/Y) in-line. the Company had a positive net financial position of €49.6 million and cash and cash equivalents totaled €259.9 million. ...
Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, today announced its financial results for the third quarter of 2022. Third Quarter 2022 H...
Leveraging the established EZ-fill ® market-leading technology, process, and product optimization to improve quality, reduce total cost of ownership, and shorten lead times Stevanato Group S.p.A. (NYSE: STVN), a global provider of drug containment, drug delivery...
Stevanato Group ( NYSE: STVN ) and DWK Life Sciences entered a non-exclusive agreement for the distribution and sale of the EZ-fill Ready-to-Use solutions (or RTU) by Stevanato Group. The collaboration will leverage DWK Life Sciences’ experience in supplying a ...
Stevanato Group aims to expand distribution of EZ-fill® whose proven advantages have turned its processing technology into an industry standard for Ready-To-Use products. Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment and deli...
Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it will issue financial results for the third quarter of 2022 on Tuesday, ...
Bexson Biomedical and Stevanato Group Awarded PDA Drug Delivery Innovation Award PR Newswire SANTA BARBARA, Calif. , Oct. 19, 2022 /PRNewswire/ -- Bexson Biomedical, Inc., a biopharmaceutical company focused on disrupting the $189 billion small mo...
Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that management will present at the Bank of America Global Healthcare Conferenc...
News, Short Squeeze, Breakout and More Instantly...
Stevanato Group S.p.A. Company Name:
STVN Stock Symbol:
NYSE Market:
Stevanato Group S.p.A. Website:
Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, announced today that it will issue financial results for the second quarter of 2024 on Tuesday, August 6, 2...
2024-07-04 19:32:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-24 21:18:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...